Who
Arthur F. Ryan
Director
Company insider
Files Form 4 as: Director, Regeneron Pharmaceuticals; Director, Citizens Financial Group; Director, Universal Business Payment Solutions Acquisition; Chairman, Prudential Financial.
In numbers
- Trades disclosed
- 903
- Buys
- 3
- Sells
- 65
- Bought
- $1.2M
- Sold
- $60.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 3 Jan 2006
- Last trade
- 2 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jul 2026filed 7 Jul 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $130K200 at $650.15 | filing |
| 2 Jul 2026filed 7 Jul 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $130K200 at $650.15 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $3,5095 at $701.76 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $3,5575 at $711.49 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $7121 at $712.09 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1,4282 at $714.13 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $11K15 at $702.46 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $17K24 at $703.46 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $11K15 at $704.28 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $9,87814 at $705.56 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,9477 at $706.74 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $2,8304 at $707.40 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,2576 at $709.45 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $3,5095 at $701.76 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $11K15 at $702.46 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $17K24 at $703.46 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $11K15 at $704.28 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $9,87814 at $705.56 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,9477 at $706.74 | filing |
| 1 May 2026filed 4 May 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $2,8304 at $707.40 | filing |
The newest 500 lines are listed; the numbers count every line.
News
1,598 Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Perpetual LtdREGN · dailypolitical.com · 15 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% – Here's What HappenedREGN · dailypolitical.com · 14 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $780.00REGN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Arthur F. Ryan; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.